These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

187 related articles for article (PubMed ID: 9651737)

  • 1. Catecholamine levels and treatment in chronic heart failure.
    Anker SD
    Eur Heart J; 1998 Jun; 19 Suppl F():F56-61. PubMed ID: 9651737
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Prognosis of heart failure--value of drug therapy].
    Felix SB
    Z Kardiol; 1996; 85 Suppl 4():1-7. PubMed ID: 9027102
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Angiotensin II receptor antagonists and heart failure: angiotensin-converting-enzyme inhibitors remain the first-line option.
    Prescrire Int; 2005 Oct; 14(79):180-6. PubMed ID: 16285075
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Potential novel pharmacological therapies for myocardial remodelling.
    Landmesser U; Wollert KC; Drexler H
    Cardiovasc Res; 2009 Feb; 81(3):519-27. PubMed ID: 19019834
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Heart failure in coronary heart disease].
    Hauf GF; Roskamm H
    Internist (Berl); 1993 Oct; 34(10):953-60. PubMed ID: 8225845
    [No Abstract]   [Full Text] [Related]  

  • 6. Role of sympathetic nervous system in hypertension and effects of cardiovascular drugs.
    Noll G; Wenzel RR; Binggeli C; Corti C; Lüscher TF
    Eur Heart J; 1998 Jun; 19 Suppl F():F32-8. PubMed ID: 9651733
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Eplerenone: new drug. Recent myocardial infarction with heart failure: a spironolactone me too.
    Prescrire Int; 2006 Apr; 15(82):46-9. PubMed ID: 16604728
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Role of growth hormone in chronic heart failure: therapeutic implications.
    Volterrani M; Giustina A; Manelli F; Cicoira MA; Lorusso R; Giordano A
    Ital Heart J; 2000 Nov; 1(11):732-8. PubMed ID: 11110515
    [TBL] [Abstract][Full Text] [Related]  

  • 9. How to protect the heart in septic shock: a hypothesis on the pathophysiology and treatment of septic heart failure.
    Schmittinger CA; Wurzinger B; Deutinger M; Wohlmuth C; Knotzer H; Torgersen C; Dünser MW; Hasibeder WR
    Med Hypotheses; 2010 Mar; 74(3):460-5. PubMed ID: 19889504
    [TBL] [Abstract][Full Text] [Related]  

  • 10. High-versus low-dose ACE inhibitor therapy in chronic heart failure.
    Roffman DS
    Ann Pharmacother; 2004 May; 38(5):831-8. PubMed ID: 15026561
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [New therapeutic prospects in heart failure. ACE inhibitors and beta blockers].
    Capone A; Carfagna P; Paravati V; Bianco G; Battista M; Brandimarte C
    Recenti Prog Med; 1999 Mar; 90(3):136-42. PubMed ID: 10228352
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Optimal management of chronic heart failure in patients with chronic kidney disease.
    Zachariah D; Kalra PA; Kalra PR
    J Ren Care; 2009 Mar; 35(1):2-10. PubMed ID: 19200271
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Determinants of increased angiotensin II levels in severe chronic heart failure patients despite ACE inhibition.
    van de Wal RM; Plokker HW; Lok DJ; Boomsma F; van der Horst FA; van Veldhuisen DJ; van Gilst WH; Voors AA
    Int J Cardiol; 2006 Jan; 106(3):367-72. PubMed ID: 16337046
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of catecholamine-beta-adrenoceptor-cAMP system on severe patients with heart failure.
    Peng Y; Shan J; Qi X; Xue H; Rong C; Yao D; Guo Z; Zheng S
    Chin Med J (Engl); 2003 Oct; 116(10):1459-63. PubMed ID: 14570600
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Modern therapy of cardiac insufficiency].
    Stojsić D; Jelkić N
    Med Pregl; 1999; 52(3-5):113-24. PubMed ID: 10518395
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Renal function as a predictor of prognosis in chronic heart failure.
    Hillege H; Van Gilst W; de Zeeuw D; van Veldhuisen DJ
    Heart Fail Monit; 2002; 2(3):78-84. PubMed ID: 12634888
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inhibiting the renin-angiotensin system in myocardial infarction and heart failure: lessons from SAVE, VALIANT and CHARM, and other clinical trials.
    Tokmakova M; Solomon SD
    Curr Opin Cardiol; 2006 Jul; 21(4):268-72. PubMed ID: 16755193
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Addition of beta blockers in chronic heart failure].
    Missault LH; van Veldhuisen DJ
    Ned Tijdschr Geneeskd; 2000 Sep; 144(40):1905-10. PubMed ID: 11045137
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Is the efficacy of positive inotropic drugs limited to symptomatic improvement?
    Baumann G; Felix SB
    Herz; 1991 Sep; 16 Spec No 1():304-13. PubMed ID: 1820297
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Angiotensin-converting enzyme inhibitors :from vasoactive drugs to cardiovascular prevention tools].
    Modesti PA; Vanni S; Gensini GF
    Ital Heart J Suppl; 2003 Aug; 4(8):623-34. PubMed ID: 14655458
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.